Rare diseases
Investigational molecules
Locations
Back to Germany141 clinical trials in Herne, Germany across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study on the Long-Term Safety of Seladelpar for Patients with Primary Biliary Cholangitis
GermanyStudy on Durvalumab, Tremelimumab, and Enfortumab Vedotin for Patients with Muscle Invasive Bladder Cancer Ineligible or Refusing Cisplatin
GermanyStudy Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients
GermanyGermanyStudy on Long-Term Safety and Efficacy of Ianalumab for Patients with Sjögren’s Syndrome
GermanyStudy Comparing Obinutuzumab and Venetoclax with Obinutuzumab and Chlorambucil for Untreated Chronic Lymphocytic Leukemia Patients with Other Health Conditions
GermanyStudy of Adagrasib and Cetuximab for Patients with Advanced Colorectal Cancer with KRAS G12C Mutation After First-Line Therapy
GermanyStudy Comparing Enfortumab Vedotin and Pembrolizumab with Chemotherapy for Patients with Muscle-Invasive Bladder Cancer
GermanyStudy of Sacituzumab Govitecan for Patients with Advanced or Metastatic Bladder Cancer
GermanyGermanyStudy on Isatuximab, Lenalidomide, Bortezomib, and Dexamethasone for Patients with Newly Diagnosed Low-Risk Multiple Myeloma
GermanyStudy on the Effectiveness and Safety of AP707 and Naproxen for Patients with Chronic Back Pain
GermanyThe busiest research cities in the country
What the registry says about research in the country
Innovative clinical trials focusing on colorectal cancer, bladder cancer, and prostate cancer treatments. Studies evaluate novel therapeutic combinations and targeted approaches for improved patient outcomes.
Multiple studies are exploring combination therapies and comparing treatment efficacy in various cancer stages.
Comprehensive research into psoriatic arthritis, rheumatoid arthritis, and axial spondyloarthritis. Trials evaluate new biological treatments and therapeutic approaches.
Focus on improving treatment outcomes for patients with various rheumatic conditions.
Advanced studies in chronic lymphocytic leukemia and acute myeloid leukemia. Investigations of innovative treatment combinations and targeted therapies.
Clinical trials aim to improve survival rates and treatment effectiveness in blood cancers.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
